Tech Company Financing Transactions

Tentarix Biotherapeutics Funding Round

Tentarix Biotherapeutics closed a $50 million Series A funding round on 10/18/2021. Investors included Samsara BioCapital, Versant Ventures and private investors.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

10355 Science Center Dr. 120
San Diego, CA 92121
USA

Phone

(858) 866-8832

Website

www.tentarix.com

Email Address

[email protected]

Overview

Tentarix's mission is to develop first-in-class targeted, multifunctional, conditional therapies. The Company is focused on modalities that have cell specific function and has built a team that aims to transform biologics.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Paul Grayson

        

Chief Financial Officer

Alyssa Levin

        

Chief Scientific Officer

Stephen Demarest

        

Chief Technical Officer

Michael Gallo

        

VP - Bus. Development

Paul Kang

        

VP - Bus. Development

Margaret Karow

        

Browse more venture capital transactions:

Prev: 10/18/2021: Matik venture capital transaction
Next: 10/18/2021: Space Perspective venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to record every notable VC transaction. All VC database entries reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary